stockrowGuardant Health, Inc. (GH) vs QIAGEN N.V. (QGEN)
- Guardant Health, Inc. GH 154.16 −8.55%
- QIAGEN N.V. QGEN 50.88 +0.10%
Guardant Health, Inc. and QIAGEN N.V. are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $20.6B against $10.5B — 2.0× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; QIAGEN N.V. trades at 26.1×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs −37.9%) and the higher return on invested capital (6.62% vs −25.7%). Across the 18 metrics below, QIAGEN N.V. leads on 11 and Guardant Health, Inc. on 7.
Valuation
Profitability
| Metric | GH | QGEN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.19% | 62.20% | 48.32% |
| Operating margin | (39.41%) | 21.21% | (5.68%) |
| Net margin | (37.93%) | 19.49% | (4.10%) |
| Free cash flow margin | (18.15%) | 20.98% | 0.00% |
| Return on equity | 153.90% | 11.93% | 0.00% |
| Return on assets | (30.68%) | 6.99% | (6.05%) |
| Return on invested capital | (25.68%) | 6.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack